Recombinant LAG3 (Encelimab Biosimilar) antibody
This anti-LAG3 (Encelimab Biosimilar) antibody is a Human Monoclonal antibody detecting LAG3 (Encelimab Biosimilar) in BLI, ELISA, FACS, Func and SPR. Suitable for Human.
Catalog No. ABIN7676045
-15% Promotion 2026
$294.23
save $51.92 (-15 %)
Plus shipping costs $50.00
Shipping to:
United States
Delivery in 10 to 11 Business Days
Quick Overview for Recombinant LAG3 (Encelimab Biosimilar) antibody (ABIN7676045)
Target
LAG3 (Encelimab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Human
Clonality
Monoclonal
Conjugate
This LAG3 (Encelimab Biosimilar) antibody is un-conjugated
Application
Bio-Layer Interferometry (BLI), ELISA, Flow Cytometry (FACS), Functional Studies (Func), Surface Plasmon Resonance (SPR)
-
-
Expression System
- CHO Cells
-
Purpose
- Anti-LAG3 / CD223 Reference Antibody (encelimab)
-
Characteristics
- Anti-LAG3 / CD223 Reference Antibody (encelimab) is expressed from CHO. The heavy chain type is huIgG4SP, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.
-
Purity
- >95 %
-
Isotype
- IgG4 S228P
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- 1 mg/mL
-
Buffer
- 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2
-
Storage
- 4 °C,-80 °C
-
Storage Comment
- +4°C,-80°C
-
-
- LAG3 (Encelimab Biosimilar)
-
Target Type
- Biosimilar
-
Molecular Weight
- 145.5 kDa
-
UniProt
- P18627
Target
-
You are here:
